Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma
Clinical trial NCT03919175 · TERMINATED
Trial details
- NCT number
- NCT03919175
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2024-05-05
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.